Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Allergan says FDA approved new version of Lumigan for treating conditions related to glaucoma
Yahoo/AP
Wednesday, September 1, 2010 - 6:47am
tags:
Allergan, glaucoma, FDA, Lumigan
5 Drugmakers With Killer Dividends
Motley Fool
Wednesday, September 1, 2010 - 6:46am
tags:
dividends, Pfizer, Merck, JNJ, Eli Lilly, Bristol-Myers Squibb
The Dangers Of Information Restrictions On Drugs’ Off-Label Uses
Forbes
Tuesday, August 31, 2010 - 6:49pm
tags:
off-label, FDA
What does your CEO think about Pharmaceutical Sales Representatives?
Pharmareform
Tuesday, August 31, 2010 - 5:43pm
tags:
Pharma CEOs, drug reps
Why Roche Employees Will Pay With Their Jobs for Cancer Drug Avastin’s Success
BNET Pharma
Tuesday, August 31, 2010 - 5:40pm
tags:
Roche, layoffs, Avastin, cancer
Genzyme for sale at right price, says CEO
Marketwatch
Tuesday, August 31, 2010 - 5:39pm
tags:
Genzyme, Henri Termeer, M&A, Sanofi
Catalyst for Pfizer and Bristol Expected in 2011
Minyanville
Tuesday, August 31, 2010 - 5:38pm
tags:
Pfizer, Bristol-Myers Squibb, Apixaban
J&J's Latest Recalls Cloud Outlook
TheStreet.com
Tuesday, August 31, 2010 - 1:05pm
tags:
recalls, DePuy, JNJ
Why Amgen Should Buy Genzyme
Forbes
Tuesday, August 31, 2010 - 1:03pm
tags:
Amgen, M&A, Genzyme, Sanofi
Halozyme preps for FDA meeting on recalled drug
Fierce Pharma
Tuesday, August 31, 2010 - 1:02pm
tags:
recalls, Halozyme, FDA, Baxter International, Hylenex
9 Biotech Penny Stocks to Buy
TheStreet.com
Tuesday, August 31, 2010 - 12:13pm
tags:
Athersys, Catalyst, Inhibitex, Rexahn, Cyclacel, Neuralstem, Luna Innovations, AVI BioPharma, DUSA pharmaceuticals
Dynavax gets grant for hepatitis B work
Bizjournals.com
Tuesday, August 31, 2010 - 12:11pm
tags:
Dynavax, hepatitis B, grants
Forest Laboratories faces key FDA panel meeting next week over antibiotic ceftaroline
Yahoo/AP
Tuesday, August 31, 2010 - 12:09pm
tags:
Forest Labs, FDA, advisory panels, antibiotics, ceftaroline
FDA To Baxter: Start Telling The Truth
Pharmalot
Tuesday, August 31, 2010 - 12:08pm
tags:
Baxter International, FDA, Aralast
Cervarix license amended for additional HPV strains
Vaccine News Daily
Tuesday, August 31, 2010 - 12:07pm
tags:
vaccines, GSK, Cervarix, HPV
21 Drugs Facing FDA Approval Decisions
TheStreet.com
Tuesday, August 31, 2010 - 12:05pm
tags:
FDA, Questcor Pharmaceuticals, Savient, Alkermes, Arena Pharmaceuticals, Roche, Novartis, Hospira, Human Genome, Alexza, Jazz Pharmaceuticals, Biodel, Amylin, Eli Lilly, Vivus, Avanir, Cadence Pharmaceuticals, Amgen, Cumberland, Orexigen, MannKind, Bristol-Myers Squibb
Pfizer Clot Drug Beats Aspirin in Research, May Enter $10 Billion Market
Bloomberg
Tuesday, August 31, 2010 - 7:44am
tags:
Pfizer, blood thinners, Apixaban
AstraZeneca considering options after failing to win US approval for respiratory drug
Yahoo/AP
Tuesday, August 31, 2010 - 7:42am
tags:
AstraZeneca, FDA, motavizumab
Glaxo, Valeant face US delay for epilepsy drug
Yahoo/AP
Tuesday, August 31, 2010 - 7:22am
tags:
epilepsy, GSK, Valeant Pharmaceuticals, ezogabine, FDA
Pipeline Checkup: Merck Has Potential
Motley Fool
Tuesday, August 31, 2010 - 7:17am
tags:
Merck, Vorapaxar, Boceprevir, Odanacatib

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.